Equities

Hellenic Dynamics PLC

HELD:LSE

Hellenic Dynamics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.78
  • Today's Change0.00 / 0.00%
  • Shares traded8.03m
  • 1 Year change-90.90%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 16:21 BST.
More ▼

Profile data is unavailable for this security.

About the company

Hellenic Dynamics Plc is a United Kingdom-based cultivator and supplier of finished pharmaceutical standard medical cannabis products. The Company is involved in the cultivation, production and export of tetrahydrocannabinol (THC) dominant strains of dried medical cannabis flowers and flower extracts to the medical cannabis markets across Europe. The Company develops and operates approximately 40,000 square meter active cultivation license from its 195,506 square meter facility located near Thessaloniki in Northern Greece. The Company is capable of producing over 54,000 kilograms (kg) of dried flowers per annum.

  • Revenue in GBP (TTM)--
  • Net income in GBP--
  • Incorporated2007
  • Employees25.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Ovoca Bio PLC0.00-2.00m590.07k5.00590.07k5.00
Voyager Life PLC314.00k-1.10m630.13k28.00630.13k28.00
Nuformix PLC0.00-436.95k1.52m2.001.52m2.00
Oxford Cannabinoid Tchnlgs Hldngs PLC0.00-4.24m1.69m7.001.69m7.00
ReNeuron Group Plc249.00k-5.07m1.93m34.001.93m34.00
N4 Pharma PLC1.95k-1.28m2.15m5.002.15m5.00
Hellenic Dynamics PLC-100.00bn-100.00bn2.53m25.002.53m25.00
ValiRx Plc9.60k-2.04m2.91m8.002.91m8.00
TheraCryf PLC838.00k-3.35m3.21m7.003.21m7.00
Fusion Antibodies PLC1.58m-2.84m3.24m50.003.24m50.00
IXICO PLC6.67m-1.18m3.57m89.003.57m89.00
BSF Enterprise PLC12.94k-1.50m4.91m4.004.91m4.00
Data as of May 17 2024. Currency figures normalised to Hellenic Dynamics PLC's reporting currency: UK Pound GBX
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.